Browse the evidence

Impaired kisspeptin signaling (Kiss1r KO) in adult female mice causes obesity, glucose intolerance, and reduced energy expenditure independent of gonadal estrogen levels.

This research suggests that metabolic health is regulated by complex hormonal signaling (kisspeptin) beyond just reproductive hormones. In females, impaired signaling leads to reduced energy expenditure and glucose intolerance, independent of estrogen levels. This highlights the importance of hormonal balance in metabolic health, particularly for women.

The glycemic benefits of moderate wine consumption in type 2 diabetes are conditional on the ADH1B genotype, specifically benefiting 'slow ethanol metabolizers' (ADH1B*1 carriers) while showing no benefit or potential harm in 'fast metabolizers' (ADH1B*2 homozygotes).

If you have type 2 diabetes, your body's ability to process alcohol depends on your genetics. If you are a 'slow metabolizer' (common in certain populations), moderate wine might help your blood sugar. If you are a 'fast metabolizer,' it may not help or could worsen control. Without genetic testing, the safest approach for glycemic control is abstinence or extreme caution, as the benefit is not universal.

Increasing skeletal muscle expression of Estrogen-related Receptor gamma (ERRγ) via genetic overexpression or pharmacological agonism shifts muscle phenotype toward slow-twitch oxidative fibers, thereby increasing mitochondrial function and endurance exercise capacity.

This research suggests that targeting the ERRγ pathway could be a potential therapeutic strategy for conditions like obesity or sarcopenia, where oxidative metabolism is reduced. For now, exercise itself naturally induces ERRγ expression, which contributes to improved mitochondrial function and endurance. Future therapies might mimic this effect pharmacologically.

In young subjects with early-onset type 2 diabetes, chronic aerobic exercise fails to activate the PGC-1α/Mfn2 mitochondrial regulatory pathway, resulting in a lack of increase in VO2max and defective mitochondrial biogenesis compared to obese controls.

For young individuals with early-onset type 2 diabetes, standard aerobic exercise may not trigger the usual mitochondrial improvements seen in healthy individuals. This biological resistance means that while exercise is still beneficial for other health markers, it may not improve cardiovascular fitness (VO2max) or insulin sensitivity as expected. This highlights the need for personalized exercise prescriptions or adjunctive therapies to overcome this specific molecular defect.

Vigorous exercise training (4 hours/week at ~70% VO2max) does not independently improve insulin sensitivity or glucose disposal in lean, obese, or diabetic men when body weight and composition are strictly maintained.

If you want to improve insulin sensitivity through exercise, you cannot just exercise and eat back all the calories. This study shows that vigorous training (4 hours/week) does NOT improve insulin sensitivity if you maintain your exact weight and body fat. To get the metabolic benefit, you must create an energy deficit (lose weight/fat). Exercise alone, without weight loss, is metabolically neutral for insulin sensitivity in this population.

Obese individuals exhibit differential brain activation patterns in response to satiation compared to lean individuals, specifically showing greater prefrontal cortex activation and attenuated hypothalamic deactivation, suggesting altered neural inhibition of orexigenic networks.

This research suggests that obesity involves specific, measurable differences in how the brain processes hunger and fullness signals, particularly involving the prefrontal cortex and hypothalamus. This implies that standard dietary advice might need to account for these neural differences, potentially requiring strategies that support satiety signaling or address the specific neural pathways involved in food reward and inhibition, rather than assuming a uniform brain response to food across all body types.

The risk reduction of new-onset atrial fibrillation following bariatric surgery is significantly greater in younger individuals and those with higher baseline diastolic blood pressure.

Younger patients with severe obesity and high blood pressure are likely to derive the greatest protective benefit against atrial fibrillation from bariatric surgery. The protective effect diminishes in older patients and those with lower baseline blood pressure, though the overall risk reduction remains significant.

Adolescent depression is a strong longitudinal predictor of binge eating symptoms and eating disorder diagnosis in young adulthood for both men and women.

If you or your adolescent child is experiencing depression, be aware that this is a strong predictor for developing binge eating and eating disorders later in life. This applies to both men and women. Addressing depression early may help prevent these eating-related health problems.

In older men, higher plasma dihydrotestosterone (DHT) levels (above the median) are associated with significantly reduced ischemic heart disease (IHD) mortality, independent of testosterone levels.

For older men, higher natural levels of DHT (the metabolite of testosterone) are linked to a lower risk of dying from heart disease. This suggests that the conversion of testosterone to DHT may have cardioprotective benefits, although this does not necessarily mean exogenous DHT supplementation is safe or recommended without medical supervision.

Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance by allowing bacterial translocation into metabolic tissues.

This research suggests that for some individuals, insulin resistance may be driven by gut bacteria leaking into metabolic tissues due to specific immune system variations (NOD2). While this is a mouse study, it highlights that gut health and immune sensing are critical factors in metabolic disease, potentially beyond just calories.

In obese individuals, lower resting energy expenditure (REE) relative to predicted levels is associated with significantly lower circulating active ghrelin levels and reduced ghrelin activity.

If you are obese and struggling with weight loss, your body's hormonal response (ghrelin) may be suppressed more severely if your resting energy expenditure is low. This suggests that metabolic rate is a key factor in hunger regulation, and treatments or strategies that address metabolic efficiency might be more effective than those focusing solely on caloric intake.

Elevated baseline plasma copeptin levels independently predict the future development of type 2 diabetes and abdominal obesity, suggesting a primary role for the vasopressin system in cardiometabolic risk.

High copeptin levels, a marker of vasopressin activity, are associated with a higher risk of developing type 2 diabetes and abdominal obesity over the long term. While copeptin itself is not a treatment target, its elevation signals a dysregulated system. Focus on maintaining a healthy waist circumference and blood sugar levels through diet and exercise, as these factors influence the vasopressin system and reduce cardiometabolic risk.

Elevated baseline plasma copeptin levels independently predict the future development of microalbuminuria, even after adjusting for incident diabetes and hypertension.

High copeptin levels are associated with an increased risk of microalbuminuria, an early sign of kidney and cardiovascular damage, independent of diabetes and high blood pressure. This suggests that vasopressin system dysregulation directly impacts kidney health. Managing weight and blood sugar may help mitigate this risk.

Elevated baseline plasma copeptin levels do NOT independently predict the development of the full metabolic syndrome cluster, despite predicting its individual components (DM and abdominal obesity).

While high copeptin levels predict individual risks like diabetes and abdominal obesity, they do not predict the full metabolic syndrome cluster. This highlights the complexity of metabolic health and the importance of addressing individual risk factors rather than relying on a single biomarker for syndrome prediction.

Physical activity significantly increases Sex Hormone Binding Globulin (SHBG) and decreases free testosterone, androstenedione, and DHEA-sulfate in women.

Exercise helps improve your hormonal profile by increasing SHBG (which binds excess hormones) and lowering free testosterone and other androgens. This is particularly beneficial for women with PCOS, where SHBG increases were most pronounced.

Obesity causes a shift in HDL subclass distribution from large, protective HDL2 particles to small, dense HDL3 particles, and impairs HDL functionality, including reduced cholesterol efflux capacity and anti-inflammatory properties.

Obesity doesn't just lower your HDL cholesterol number; it makes the HDL you have less effective at protecting your heart. This happens because excess fat increases enzymes that break down HDL and reduces protective proteins like adiponectin. To counter this, focus on weight loss and reducing inflammation, as these changes can restore HDL function and shift the balance back to more protective HDL particles.

Insulin resistance drives hepatic steatosis by disrupting normal insulin signaling, leading to unchecked de novo lipogenesis and increased free fatty acid flux from visceral adipose tissue.

Focus on improving insulin sensitivity through lifestyle changes, as insulin resistance is the primary driver of fat accumulation in the liver. This involves managing energy intake to reduce visceral fat and free fatty acid flux, and potentially reducing carbohydrate load to lower insulin levels, thereby allowing normal lipid metabolism to resume.

Progression from simple steatosis to steatohepatitis (NASH) is driven by a 'second hit' involving oxidative stress, inflammation, and mitochondrial dysfunction, often triggered by excess free fatty acids.

Preventing progression to NASH requires reducing the metabolic load on the liver. This involves minimizing factors that cause oxidative stress and inflammation, such as excessive alcohol intake (though NAFLD is non-alcoholic, alcohol adds stress) and high sugar/fructose intake which drives de novo lipogenesis.

Adipose tissue acts as an endocrine organ in obesity, secreting inflammatory cytokines (like TNF-alpha) and adipokines (like RBP4) that induce insulin resistance in the liver and muscle.

Weight loss reduces the mass of adipose tissue, thereby reducing the secretion of inflammatory cytokines and adipokines that drive insulin resistance. This improves the body's ability to manage blood sugar and reduces fat accumulation in the liver.

Acute exercise-heat-induced dehydration without fluid replacement increases sweat sodium and chloride concentrations in men, likely due to elevated extracellular fluid sodium, plasma aldosterone, and sympathetic nervous activity.

If you exercise for more than an hour in hot conditions, your sweat becomes saltier if you don't drink. This means you lose more sodium than you would if you stayed hydrated. To maintain performance and health, consider replacing fluids with electrolytes, especially sodium, rather than just plain water, to match the increased loss.

Obesity creates a pro-inflammatory environment in white adipose tissue that impairs signaling of fibroblast growth factor 21 (FGF21) by downregulating its co-receptor β-Klotho, leading to FGF21 resistance.

In obesity, the body's natural fat-burning signals (like FGF21) get blocked by inflammation. This means that simply having high levels of these hormones doesn't work; the fat cells stop listening. Reducing inflammation may be necessary to restore these fat-burning pathways.

Gastric bypass surgery reduces appetite and promotes long-term weight loss primarily through hormonal changes, specifically decreased ghrelin and increased PYY, rather than solely mechanical restriction.

Gastric bypass surgery works largely by changing your gut hormones: it lowers hunger signals (ghrelin) and boosts fullness signals (PYY). While surgery is a major step, you can try to mimic these hormonal effects through dietary choices that naturally stimulate these gut hormones, potentially helping with long-term weight management.

Leptin treatment is effective for weight loss only in individuals with congenital leptin deficiency, but offers limited benefit for the vast majority of obese people who have high circulating leptin.

Leptin is a hormone that signals fullness, but most obese people already have high levels of it. Taking leptin supplements does not help them lose weight. It is only effective for a very rare group of people with a specific genetic deficiency. For most, lifestyle changes remain the primary approach.

Central serotonergic signaling acts as an anorexigenic mechanism in the homeostatic circuitry by integrating metabolic signals to suppress food intake when energy needs are met, whereas peripheral serotonergic signaling promotes energy absorption and storage.

Your brain uses serotonin to decide when to stop eating. This process happens in specific brain areas that listen to your body's energy signals. If this system is disrupted, you might eat more than you need, contributing to weight gain. Understanding this helps explain why some medications affecting serotonin can impact weight.